Biolase, Inc. (BIOL) Social Stream
Biolase Inc (BIOL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BIOL.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued March 22, 2022
The Trend in the Analyst Price Target
BIOL's average price target has moved up $0.59 over the prior 14 months.
Over the past 50 weeks, BIOL's average upside potential has been 219.74%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
BIOL Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
BIOL's average broker recommendation rating worsened by 0.25 over the prior 151 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BIOL as an investment opportunity.
- BIOL has a greater number of analysts covering the stock than practically none of all US stocks.
- Biolase Inc's average analyst price target is greater than 0.84% of all US stocks.
- BIOL has a lower variance in analysts' estimates than 94.15% of Healthcare stocks.
- In terms of how Biolase Inc fares relative to Medical Equipment stocks, note that its upside potential (average analyst target price relative to current price) is higher than 189.62% of that group.
Is BIOL a Buy, Hold or Sell? See the POWR Ratings now!